152 related articles for article (PubMed ID: 14567453)
21. Prevalence of non-Helicobacter pylori duodenal ulcer in Karachi, Pakistan.
Yakoob J; Jafri W; Jafri N; Islam M; Abid S; Hamid S; AliShah H; Shaikh H
World J Gastroenterol; 2005 Jun; 11(23):3562-5. PubMed ID: 15962375
[TBL] [Abstract][Full Text] [Related]
22. Review article: Helicobacter pylori-negative duodenal ulcer disease.
Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2009 Oct; 30(8):791-815. PubMed ID: 19706147
[TBL] [Abstract][Full Text] [Related]
23. Help Desk Answers: What is the optimal duration of PPI therapy for healing an ulcer?
Whealon SR; Gibbs LM
J Fam Pract; 2015 Dec; 64(12):805, 813. PubMed ID: 26845003
[No Abstract] [Full Text] [Related]
24. [Helicobacter pylori, non-steroidal anti-inflammatory drugs and aspirin: a new piece of the puzzle].
Lesur G
Gastroenterol Clin Biol; 2001; 25(6-7):725-6. PubMed ID: 11688500
[No Abstract] [Full Text] [Related]
25. Should we still look for causes other than HP and NSAID for PUD?
Koshy A; Pitchumoni CS
Am J Gastroenterol; 1998 Jul; 93(7):1187. PubMed ID: 9672367
[No Abstract] [Full Text] [Related]
26. [Helicobacter pylori, nonsteroidal anti-inflammatory agents and gastroduodenal changes].
Teixeira AV
Acta Med Port; 1995 Sep; 8(9):517-21. PubMed ID: 7484272
[TBL] [Abstract][Full Text] [Related]
27. [Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?].
Lanas Arbeloa A; Serrano Aulló MT
Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():20-4. PubMed ID: 9549198
[No Abstract] [Full Text] [Related]
28. Low prevalence of Helicobacter pylori in an Australian duodenal ulcer population: NSAIDitis or the effect of ten years of H. pylori treatment?
Henry A; Batey RG
Aust N Z J Med; 1998 Jun; 28(3):345. PubMed ID: 9673749
[No Abstract] [Full Text] [Related]
29. Pathogenesis and therapy of gastric and duodenal ulcer disease.
Shiotani A; Graham DY
Med Clin North Am; 2002 Nov; 86(6):1447-66, viii. PubMed ID: 12510460
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of Helicobacter pylori infection in duodenal ulcer and gastro-duodenal ulcer diseases in Taiwan.
Chen TS; Luo JC; Chang FY
J Gastroenterol Hepatol; 2010 May; 25(5):919-22. PubMed ID: 20074147
[TBL] [Abstract][Full Text] [Related]
31. [Pathogenesis of gastric and duodenal ulcer in the elderly].
Watanabe T; Chiba T
Nihon Rinsho; 2002 Aug; 60(8):1515-20. PubMed ID: 12187744
[TBL] [Abstract][Full Text] [Related]
32. H. pylori and risk of ulcer bleeding among users of NSAIDS.
Atherton JC; Wight NJ
Gastroenterology; 2000 Feb; 118(2):451-2. PubMed ID: 10691374
[No Abstract] [Full Text] [Related]
33. [Relationship between NSAIDs and H. pylori in peptic ulcer diseases--is the eradication of H. pylori recommended in NSAIDs ulcer?].
Ota S; Nakajima S; Bamba H
Nihon Rinsho; 2005 Nov; 63 Suppl 11():565-8. PubMed ID: 16363602
[No Abstract] [Full Text] [Related]
34. Short-term/low-dose aspirin-induced duodenal erosions are not dependent on Helicobacter pylori infection, cyclooxygenase expression and prostaglandin E2 levels.
Venerito M; Treiber G; Wex T; Kuester D; Roessner A; Mönkemüller K; Malfertheiner P
Scand J Gastroenterol; 2008; 43(7):801-9. PubMed ID: 18584518
[TBL] [Abstract][Full Text] [Related]
35. Zollinger-Ellison syndrome and antral G-cell hyperfunction in patients with resistant duodenal ulcer disease.
Annibale B; De Magistris L; Corleto V; D'Ambra G; Marignani M; Iannoni C; Delle Fave G
Aliment Pharmacol Ther; 1994 Feb; 8(1):87-93. PubMed ID: 8186351
[TBL] [Abstract][Full Text] [Related]
36. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
[TBL] [Abstract][Full Text] [Related]
37. [Indications for the eradication of Helicobacter pylori. Reflections on the Maastricht consensus conference].
Boixeda de Miquel D; Martín de Argila C; Pérez Gisbert J
Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():29-34. PubMed ID: 9549200
[No Abstract] [Full Text] [Related]
38. Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users.
Hawkey CJ; Wilson I; Naesdal J; Långström G; Swannell AJ; Yeomans ND
Gut; 2002 Sep; 51(3):344-50. PubMed ID: 12171954
[TBL] [Abstract][Full Text] [Related]
39. Ulcer risk factors: interactions between Helicobacter pylori infection, nonsteroidal use, and age.
Schubert TT; Bologna SD; Nensey Y; Schubert AB; Mascha EJ; Ma CK
Am J Med; 1993 Apr; 94(4):413-8. PubMed ID: 8475935
[TBL] [Abstract][Full Text] [Related]
40. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use.
al-Assi MT; Genta RM; Karttunen TJ; Graham DY
Endoscopy; 1996 Feb; 28(2):229-33. PubMed ID: 8739738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
